Mark E. Sutter

1.6k total citations
47 papers, 1.1k citations indexed

About

Mark E. Sutter is a scholar working on Emergency Medicine, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Mark E. Sutter has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Emergency Medicine, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Mark E. Sutter's work include Poisoning and overdose treatments (16 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Forensic Toxicology and Drug Analysis (6 papers). Mark E. Sutter is often cited by papers focused on Poisoning and overdose treatments (16 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Forensic Toxicology and Drug Analysis (6 papers). Mark E. Sutter collaborates with scholars based in United States and United Kingdom. Mark E. Sutter's co-authors include Timothy E. Albertson, Kelly P. Owen, William J. Aronson, Frederick J. Dorey, Stephen J. Freedland, Jonathan B. Ford, James Chenoweth, Daniel Colby, Brent Morgan and Michael D. Schwartz and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Preventive Medicine and Urology.

In The Last Decade

Mark E. Sutter

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Sutter United States 17 404 182 157 130 116 47 1.1k
Suman Wason United States 22 132 0.3× 290 1.6× 49 0.3× 105 0.8× 168 1.4× 47 1.1k
Philippe Lheureux Belgium 17 141 0.3× 305 1.7× 50 0.3× 78 0.6× 116 1.0× 58 1.0k
Timothy J. Wiegand United States 18 96 0.2× 461 2.5× 223 1.4× 121 0.9× 81 0.7× 63 991
G N Volans United Kingdom 22 153 0.4× 538 3.0× 111 0.7× 201 1.5× 191 1.6× 78 1.5k
Berend Mets United States 20 161 0.4× 91 0.5× 74 0.5× 130 1.0× 490 4.2× 82 1.2k
Lynda V. Wilton United Kingdom 23 160 0.4× 27 0.1× 115 0.7× 232 1.8× 124 1.1× 48 1.2k
K O Ash United States 22 275 0.7× 49 0.3× 111 0.7× 105 0.8× 156 1.3× 60 1.6k
Jesús Frías Spain 19 103 0.3× 69 0.4× 36 0.2× 228 1.8× 111 1.0× 75 1.3k
Yolande Hanssens Qatar 18 71 0.2× 116 0.6× 76 0.5× 57 0.4× 105 0.9× 48 1.1k
P Greminger Switzerland 18 347 0.9× 63 0.3× 42 0.3× 48 0.4× 282 2.4× 91 1.1k

Countries citing papers authored by Mark E. Sutter

Since Specialization
Citations

This map shows the geographic impact of Mark E. Sutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Sutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Sutter more than expected).

Fields of papers citing papers by Mark E. Sutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Sutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Sutter. The network helps show where Mark E. Sutter may publish in the future.

Co-authorship network of co-authors of Mark E. Sutter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Sutter. A scholar is included among the top collaborators of Mark E. Sutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Sutter. Mark E. Sutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dart, Richard C., Sean P. Bush, Kennon Heard, et al.. (2019). The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(abʹ)2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Annals of Emergency Medicine. 74(3). 439–449. 13 indexed citations
2.
Chenoweth, James, et al.. (2018). Transaminase and Creatine Kinase Ratios for Differentiating Delayed Acetaminophen Overdose from Rhabdomyolysis. Western Journal of Emergency Medicine. 19(4). 731–736. 11 indexed citations
3.
Albertson, Timothy E., Susan Murin, Mark E. Sutter, & James Chenoweth. (2017). The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials. PubMed. Volume 8. 175–181. 23 indexed citations
4.
Chenoweth, James, Daniel Colby, Mark E. Sutter, et al.. (2017). Massive diltiazem and metoprolol overdose rescued with extracorporeal life support. The American Journal of Emergency Medicine. 35(10). 1581.e3–1581.e5. 13 indexed citations
5.
Diercks, Deborah B., Kelly P. Owen, Jeffrey A. Kline, & Mark E. Sutter. (2016). Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathy. Clinical and Experimental Emergency Medicine. 3(4). 204–212. 5 indexed citations
6.
Sutter, Mark E., et al.. (2015). The Changing Use of Intravenous Opioids in an Emergency Department. Western Journal of Emergency Medicine. 16(7). 1079–1083. 7 indexed citations
7.
Albertson, Timothy E., James Chenoweth, Jonathan B. Ford, Kelly P. Owen, & Mark E. Sutter. (2014). Is It Prime Time for Alpha2-Adrenocepter Agonists in the Treatment of Withdrawal Syndromes?. Journal of Medical Toxicology. 10(4). 369–381. 26 indexed citations
8.
Albertson, Timothy E., Mark E. Sutter, & Andrew Chan. (2014). The Acute Management of Asthma. Clinical Reviews in Allergy & Immunology. 48(1). 114–125. 18 indexed citations
9.
Albertson, Timothy E., Michael Schivo, Amir A. Zeki, et al.. (2013). The Pharmacological Approach to the Elderly COPD Patient. Drugs & Aging. 30(7). 479–502. 7 indexed citations
10.
Ford, Jonathan B., Mark E. Sutter, Kelly P. Owen, & Timothy E. Albertson. (2013). Volatile Substance Misuse: An Updated Review of Toxicity and Treatment. Clinical Reviews in Allergy & Immunology. 46(1). 19–33. 24 indexed citations
11.
Ford, Jonathan B., et al.. (2012). Acute, Sustained Chorea in Children After Supratherapeutic Dosing of Amphetamine-Derived Medications. Pediatric Neurology. 47(3). 216–218. 12 indexed citations
12.
Diercks, Deborah B., Kelly P. Owen, Vladimir Tolstikov, & Mark E. Sutter. (2012). Urinary Metabolomic Analysis for the Identification of Renal Injury in Patients With Acute Heart Failure. Academic Emergency Medicine. 19(1). 18–23. 11 indexed citations
13.
Elms, Andrew R., Kelly P. Owen, Timothy E. Albertson, & Mark E. Sutter. (2011). Fatal myocardial infarction associated with intravenous N-acetylcysteine error. International Journal of Emergency Medicine. 4(1). 54–54. 11 indexed citations
14.
Adams, Jason Y., Mark E. Sutter, & Timothy E. Albertson. (2011). The Patient with Asthma in the Emergency Department. Clinical Reviews in Allergy & Immunology. 43(1-2). 14–29. 20 indexed citations
15.
Sutter, Mark E., et al.. (2010). Multiple Organ Transplantation after Suicide by Acetaminophen and Gunshot Wound. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Sutter, Mark E., Arthur Chang, Michael D. Schwartz, et al.. (2010). Transportation-Related Hazardous Materials Incidents and the Role of Poison Control Centers. American Journal of Preventive Medicine. 38(6). 663–666.
17.
Sutter, Mark E., et al.. (2010). Hemodialysis Complications of Hydroxocobalamin: A Case Report. Journal of Medical Toxicology. 6(2). 165–167. 21 indexed citations
18.
Sutter, Mark E., Samuel D. Turnipseed, Deborah B. Diercks, Peter A. Samuel, & Richard H. White. (2008). Venous Ultrasound Testing for Suspected Thrombosis: Incidence of Significant Non-Thrombotic findings. Journal of Emergency Medicine. 36(1). 55–59. 12 indexed citations
19.
Freedland, Stephen J., Mark E. Sutter, Frederick J. Dorey, & William J. Aronson. (2003). Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Urology. 61(2). 365–369. 219 indexed citations
20.
Freedland, Stephen J., Mark E. Sutter, John Naitoh, et al.. (2000). Clinical characteristics in black and white men with prostate cancer in an equal access medical center. Urology. 55(3). 387–390. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suman Wason Breakdown of academic impact, for papers by Philippe Lheureux Breakdown of academic impact, for papers by Timothy J. Wiegand Breakdown of academic impact, for papers by G N Volans Breakdown of academic impact, for papers by Berend Mets Breakdown of academic impact, for papers by Lynda V. Wilton Breakdown of academic impact, for papers by K O Ash Breakdown of academic impact, for papers by Jesús Frías Breakdown of academic impact, for papers by Yolande Hanssens Breakdown of academic impact, for papers by P Greminger
Rankless by CCL
2026